DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Household
Author Program NEWCreate Narrative
CLX logo

The Clorox Company Stock Price

NYSE:CLX Community·US$10.7b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 115 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

CLX Share Price Performance

US$87.76
-35.75 (-28.95%)
​
US$101.71
Fair Value
US$87.76
-35.75 (-28.95%)
13.7% undervalued intrinsic discount
US$101.71
Fair Value
Price US$87.76
AnalystConsensusTarget US$101.71
AnalystHighTarget US$133.25
AnalystLowTarget US$77.00
Thu, 6 Aug 26
Fair ValueUS$101.71
Share Pricen/a

CLX Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value US$101.71 13.7% undervalued intrinsic discount

Analysts Lower Clorox Price Target Amid Service Disruptions and Muted Profit Outlook

0users have liked this narrative
0users have commented on this narrative
42users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value US$133.25 34.1% undervalued intrinsic discount

Rising Global Health Awareness And ERP Transformation Will Expand Demand

0users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value US$77 14.0% overvalued intrinsic discount

Consumer Shifts And Rising Compliance Costs Will Erode Margins

0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
CLX logo
Clorox
13.7% undervalued intrinsic discount

Analysts Lower Clorox Price Target Amid Service Disruptions and Muted Profit Outlook

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 6 Aug
Read Narrative
CLX logo
Clorox
34.1% undervalued intrinsic discount

Rising Global Health Awareness And ERP Transformation Will Expand Demand

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Updated 21 Aug
Read Narrative
CLX logo
Clorox
14.0% overvalued intrinsic discount

Consumer Shifts And Rising Compliance Costs Will Erode Margins

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 8 Jul
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystHighTarget
CLX logo

CLX: GOJO Integration And ERP Gains Will Support Long Term Earnings

Fair Value: US$133.25 34.1% undervalued intrinsic discount
7 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystConsensusTarget
CLX logo

CLX: GOJO Deal And Leadership Transition Will Shape Healthcare Portfolio Outlook

Fair Value: US$101.71 13.7% undervalued intrinsic discount
42 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystLowTarget
CLX logo

CLX: Mounting Execution Risks Around GOJO Integration Will Pressure Future Earnings Power

Fair Value: US$77 14.0% overvalued intrinsic discount
3 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Good value average dividend payer.

2 Risks
2 Rewards
View Full Analysis

The Clorox Company Key Details

US$6.7b

Revenue

US$3.9b

Cost of Revenue

US$2.8b

Gross Profit

US$2.3b

Other Expenses

US$587.0m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
4.85
42.32%
8.74%
2,011.1%
View Full Analysis

About CLX

Founded
1913
Employees
9200
CEO
Linda Rendle
WebsiteView website
www.thecloroxcompany.com

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The company home care cleaning and disinfecting products and laundry additives, skin sanitization and cleaning products, professional cleaning and disinfecting products, and professional food service products under the Clorox, Clorox2, Pine-Sol, Scentiva, Tilex, Liquid-Plumr, Formula 409, Purell, GOJO, CloroxPro, Clorox Healthcare, Hidden Valley, Poett, Clorinda, and Chux brands. It also provides bags and wraps, cat litter, and grilling products under the Glad, Fresh Step, Scoop Away, Kingsford, and Ever Clean brands; and dressings, dips, seasonings, sauces, water-filtration products, and natural personal care products under the Brita and Burt’s Bees brands. The company sells its products through mass retailers; grocery outlets; warehouse clubs; dollar stores; home hardware centers; drug, pet, and military stores; third-party and owned e-commerce channels; distributors; and other retail outlets through direct sales force. The company was founded in 1913 and is headquartered in Oakland, California.

Recent CLX News & Updates

Seeking Alpha • Aug 21

Clorox: A Better Business, But Too Much Growth Is Priced In

Summary I reiterate a Hold rating on The Clorox Company, as the current valuation requires unsustainably high free cash flow growth. Recent positives include the GOJO acquisition and ERP rollout, but organic revenue growth remains limited after adjusting for these factors. CLX's balance sheet is heavily leveraged post-acquisition, constraining reinvestment and raising dividend sustainability concerns. Despite optimism around wellness trends, I see an insufficient margin of safety at current prices and recommend monitoring for a significant price drop. Read the full article on Seeking Alpha
User avatar
Narrative Update • Aug 21

CLX: GOJO Integration And ERP Gains Will Support Long Term Earnings

The updated analyst price target for Clorox has shifted lower by about $8 per share, with analysts pointing to wider uncertainty around FY27 earnings, softer recent share trends and the potential for increased reinvestment under new leadership as key factors. Analyst Commentary Recent Street research on Clorox shows a mix of caution and optimism, with several bullish analysts lifting price targets even as others trim expectations on longer term earnings guidance.

Recent updates

No updates

The Clorox Company Competitors

CL logo

Colgate-Palmolive

Symbol: NYSE:CL
Market cap: US$70.1b
EL logo

Estée Lauder Companies

Symbol: NYSE:EL
Market cap: US$34.9b
KVUE logo

Kenvue

Symbol: NYSE:KVUE
Market cap: US$34.2b
KMB logo

Kimberly-Clark

Symbol: NasdaqGS:KMB
Market cap: US$32.6b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide